Cargando…
Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia
The high index of simultaneous incidence of hypertension and hypercholesterolemia in the population of many countries demands the preparation of more efficient drugs. Therefore, there is a significant area of opportunity to provide as many alternatives as possible to treat these illnesses. Taking ad...
Autores principales: | Martínez-Jiménez, Cecilia, Cruz-Angeles, Jorge, Videa, Marcelo, Martínez, Luz María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225140/ https://www.ncbi.nlm.nih.gov/pubmed/30154310 http://dx.doi.org/10.3390/molecules23092161 |
Ejemplares similares
-
Effect of Basic Amino Acids on Folic Acid Solubility
por: Pérez-Carreón, Karen, et al.
Publicado: (2023) -
Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time
por: Martínez, Luz María, et al.
Publicado: (2016) -
Mechanical Activation by Ball Milling as a Strategy to Prepare Highly Soluble Pharmaceutical Formulations in the Form of Co-Amorphous, Co-Crystals, or Polymorphs
por: Martínez, Luz María, et al.
Publicado: (2022) -
Magnesium Sulfate in combination with Nifedipine in the treatment of Pregnancy-Induced Hypertension
por: Xiang, Cuiping, et al.
Publicado: (2020) -
Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying
por: Craye, Goedele, et al.
Publicado: (2015)